Evofem Biosciences, Inc.

OTC:EVFM

0.06 (USD) • At close November 27, 2023
Bedrijfsnaam Evofem Biosciences, Inc.
Symbool EVFM
Munteenheid USD
Prijs 0.07
Beurswaarde 15,117,269
Dividendpercentage 0%
52-weken bereik 0.055 - 11.875
Industrie Biotechnology
Sector Healthcare
CEO Ms. Saundra Pelletier
Website https://www.evofem.com

An error occurred while fetching data.

Over Evofem Biosciences, Inc.

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an antimicrobial vaginal gel for the

Vergelijkbare Aandelen

Acorda Therapeutics, Inc. logo

Acorda Therapeutics, Inc.

ACOR

0.661 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)